ASPALOG Trademark

Trademark Overview

On Monday, June 29, 2020, a trademark application was filed for ASPALOG with the United States Patent and Trademark Office. The USPTO has given the ASPALOG trademark a serial number of 90026614. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by Wockhardt Bio AG. The ASPALOG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing insulin for the treatment and prevention of diabetes; insulin; inhalers filled with insulin
aspalog

General Information

Serial Number90026614
Word MarkASPALOG
Filing DateMonday, June 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations containing insulin for the treatment and prevention of diabetes; insulin; inhalers filled with insulin
Pseudo MarkASPA LOG

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWockhardt Bio AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6300
CH
Party NameWockhardt Bio AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, June 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 1, 2023SOU EXTENSION 5 GRANTED
Thursday, May 25, 2023SOU EXTENSION 5 FILED
Thursday, June 1, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2022SOU EXTENSION 4 GRANTED
Tuesday, November 22, 2022SOU EXTENSION 4 FILED
Tuesday, November 22, 2022SOU TEAS EXTENSION RECEIVED
Friday, June 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 1, 2022SOU EXTENSION 3 GRANTED
Wednesday, June 1, 2022SOU EXTENSION 3 FILED
Wednesday, June 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 31, 2022ASSIGNED TO EXAMINER
Friday, December 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 1, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 1, 2021SOU EXTENSION 2 FILED
Wednesday, December 1, 2021SOU TEAS EXTENSION RECEIVED
Friday, May 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 26, 2021SOU EXTENSION 1 GRANTED
Wednesday, May 26, 2021SOU EXTENSION 1 FILED
Wednesday, May 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 1, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 2, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 2, 2020ASSIGNED TO EXAMINER
Tuesday, July 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 2, 2020NEW APPLICATION ENTERED

Related Keywords

aspalog insulin diabetes inhalers filled prevention treatment preparations containing pharmaceutical